CONTROL AND CORRECTION OF CARDIOVASCULAR RISKS
Main Article Content
Abstract
Cardiovascular diseases (CVDs) continue to be the leading cause of death globally. While certain risk factors such as age and genetic predisposition are beyond our control, there are several modifiable risk factors that can be managed effectively. This article aims to explore the control and correction of cardiovascular risks by focusing on lifestyle modifications, pharmacological interventions, and emerging approaches in the field.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Kannel, W. B., D'Agostino, R. B., Sullivan, L., & Wilson, P. W. (2004). Concept and usefulness of cardiovascular risk profiles. American heart journal, 148(1), 16-26.
Jeong, S. K., Cho, Y. I., Duey, M., & Rosenson, R. S. (2010). Cardiovascular risks of anemia correction with erythrocyte stimulating agents: should blood viscosity be monitored for risk assessment?. Cardiovascular drugs and therapy, 24, 151-160.
Kannel, W. B. (1997). Cardiovascular risk factors in the elderly. Coronary Artery Disease, 8(8), 565-576.
Chironi, G. N., Simon, A., Bokov, P., & Levenson, J. (2009). Correction of carotid intima‐media thickness for adaptive dependence on tensile stress: implication for cardiovascular risk assessment. Journal of Clinical Ultrasound, 37(5), 270-275.
Zanchetti, A. (2009). Bottom blood pressure or bottom cardiovascular risk? How far can cardiovascular risk be reduced?. Journal of hypertension, 27(8), 1509-1520.